Gynecomastia Extension Study
NCT00637182 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2008-03-17
Summary
The purpose of this study is to look at the effect of anastrozole (ZD1033, Arimidex™) in reducing gynecomastia in pubertal boys treated with placebo in Trial 1033US/0006 (another anastrozole study).
Conditions
- Gynecomastia
Interventions
- DRUG
-
Anastrozole
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Edward O Reiter, MD · Baystate Medical Center-Children's Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 11 Years
- Max Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-31
- Primary Completion
- 2002-06-30
- Completion
- 2002-10-31
More Related Trials
-
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
NCT00287534 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
NCT00541086 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
NCT02007512 ·Status: COMPLETED ·Phase: PHASE2
-
Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex
NCT00235937 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
NCT02311933 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
NCT04666805 ·Status: UNKNOWN
-
Casodex - Nolvadex Combination
NCT00637871 ·Status: COMPLETED ·Phase: PHASE2
-
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
NCT00217659 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer
NCT00902954 ·Status: UNKNOWN ·Phase: PHASE3
-
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects
NCT00497458 ·Status: UNKNOWN ·Phase: PHASE2
-
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
NCT04294225 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients
NCT02765373 ·Status: UNKNOWN
-
Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer
NCT00077025 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)
NCT01064635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT00049062 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
NCT01155063 ·Status: TERMINATED
-
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
NCT00553410 ·Status: COMPLETED ·Phase: PHASE3
-
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
NCT00016432 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616 ·Status: RECRUITING ·Phase: PHASE3
-
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
NCT00031850 ·Status: COMPLETED ·Phase: NA
-
Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT00010322 ·Status: TERMINATED ·Phase: PHASE3
-
Secondary Adjuvant Long Term Study With Arimidex
NCT00295620 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
NCT01151215 ·Status: TERMINATED ·Phase: PHASE2
-
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
NCT02598557 ·Status: COMPLETED ·Phase: PHASE2
-
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
NCT00265759 ·Status: COMPLETED ·Phase: PHASE3